AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

Source

World

Google says it likely thwarted effort by hacker group to use AI for ‘mass exploitation event’

May 11, 2026

Boonchai Wedmakawand | Moment | Getty Images Google’s Threat Intelligence Group said in a report on Monday that it thwarted an effort by hackers to use artificial intelligence models to “plan a mass vulnerability exploitation operation.” The group, known by the acronym GTIG, said it has “high confidence” that it recorded hackers using an AI model […]

World

Microsoft CEO Satya Nadella takes stand in Musk v. Altman trial

May 11, 2026

Chairman and CEO of Microsoft Satya Nadella delivers a speech during the World Economic Forum (WEF) Annual Meeting in Davos, Switzerland on January 20, 2026. Harun Ozalp | Anadolu | Getty Images Microsoft CEO Satya Nadella took the stand to testify in the Musk v. Altman trial in federal court in Oakland, California, on Monday. […]

World

Former Tesla CFO Deepak Ahuja joins EV battery recycler Redwood Materials

May 11, 2026

Deepak Ahuja Source: Verily Redwood Materials, the electric vehicle battery recycling business started by Tesla board member and former CTO JB Straubel, is bringing on another former Tesla executive, Deepak Ahuja, as CFO, the company announced Monday. Ahuja served as finance chief at Tesla from March 2017 to March 2019, his second term at Elon Musk’s […]